Drugs, Investigational Concept

subject area of

• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Journal Articles
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Journal Articles
• Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs  Journal Articles
• Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline  Journal Articles
• Evolving issues in the management of reflux disease?  Journal Articles
• Exposing Patients With Chronic, Stable, Exertional Angina to Placebo Periods in Drug Trials  Journal Articles
• Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials  Journal Articles
• How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch  Journal Articles
• INDs for PET Molecular Imaging Probes—Approach by an Academic Institution  Journal Articles
• N of 1 randomized trials for investigating new drugs  Journal Articles
• New Anticoagulant Drugs  Journal Articles
• New Anticoagulant Therapy  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New Antithrombotic Drugs  Journal Articles
• New anticoagulants  Conferences
• New anticoagulants.  Journal Articles
• New anticoagulants: beyond heparin, low‐molecular‐weight heparin and warfarin  Journal Articles
• New approaches to rewarding pharmaceutical innovation  Journal Articles
• New treatment models for compulsive disorders  Journal Articles
• New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses  Journal Articles
• Novel therapy for COPD  Journal Articles
• Novel therapy for asthma  Journal Articles
• Oral, Direct Factor Xa Inhibitors in Development for the Prevention and Treatment of Thromboembolic Diseases  Journal Articles
• Panic prescribing has become omnipresent during the COVID-19 pandemic  Journal Articles
• Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management  Journal Articles
• Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.  Journal Articles
• Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH  Journal Articles
• Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology  Journal Articles
• The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs  Journal Articles
• The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs  Journal Articles
• The impact of practice guidelines and funding policies on the use of new drugs in advanced non‐small cell lung cancer*  Journal Articles
• Therapeutic Peptides: New Arsenal Against Drug Resistant Pathogens  Journal Articles
• Unanswered questions in venous thromboembolism  Journal Articles